Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neuren Pharmaceuticals Ltd Announces Appointment Of Executive Chairman


Wednesday, 30 Jan 2013 07:42pm EST 

Neuren Pharmaceuticals Ltd announced that Dr. Richard Treagus has joined its Board. Dr. Treagus will also become the Board’s Executive Chairman. He will be engaged in an executive capacity to review Neuren’s business, financial and commercial strategy. He will work with Larry Glass, the Company’s Chief Executive Officer and Managing Director, in executing the Company’s business plan. 

Company Quote

0.086
0.0010 +1.18%
21 Oct 2014